孕产妇药物滥用与婴儿健康：贯穿生命历程的政策选择
Maternal substance abuse and infant health: policy options across the life course.
作者信息
Frohna J G, Lantz P M, Pollack H
机构信息
Department of Internal Medicine, University of Michigan Medical School, Ann Arbor 48109-0368, USA.
出版信息
Milbank Q. 1999;77(4):531-70, iii. doi: 10.1111/1468-0009.00151.
Maternal substance abuse is a significant contributor to infant morbidity and mortality. The setting of prenatal care has long been the focus of interventions and policies to prevent these adverse outcomes. However, substance abuse programs and policies that are designed for women who are not yet pregnant can have a significant impact upon this problem. Thus it is essential to view the female life course from a broader perspective in order to consider the full range of policy options for reducing the infant mortality and morbidity caused by maternal substance abuse. This framework also allows comparisons across and between substances and offers new directions for policy development.
母亲药物滥用是导致婴儿发病和死亡的一个重要因素。长期以来，产前护理环境一直是预防这些不良后果的干预措施和政策的重点。然而，为未怀孕女性设计的药物滥用项目和政策可能会对这个问题产生重大影响。因此，有必要从更广泛的角度审视女性的生命历程，以便考虑减少母亲药物滥用导致的婴儿死亡率和发病率的全面政策选择。这个框架还允许对不同药物之间进行比较，并为政策制定提供新的方向。
Zotero 插件